Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines
Clinical trial NCT01224015 · COMPLETED
Trial details
- NCT number
- NCT01224015
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-10-01
- Enrollment
- 684
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.